4 Topic Commentaries

Testicular Cancer Blood Test Hopes

Testicular Cancer Blood Test Hopes

• 

  Aditya Bagrodia, MD

  Urologic Oncology

  •

  University of California San Diego School of Medicine; UC San Diego Health

  "Being able to engage in translational research that radically impacts the way we care for patients with testicular cancer is incredibly rewarding." "Developing this test in partnership with my colleagues represents years of dedicated work to bring a new form of personalized medicine to testicular cancer care." — verbatim from source

  Source
• 

  Diane Simeone, MD

  Oncology

  •

  UC San Diego Health

  "This breakthrough represents the kind of investment in innovation that can save lives while improving quality of life for cancer survivors." "We regularly receive inquiries from patients all over the world and are thrilled we can now offer this advanced tool to help optimize outcomes for patients with testicular cancer." — verbatim from source

  Source
• 

  Divyanshu Dubey, M.B.B.S.

  Neurology; Laboratory Medicine and Pathology

  •

  Mayo Clinic

  "When standard blood markers are negative, diagnosis and treatment planning can be delayed." "Our findings show a promising path toward a more sensitive blood test approach, but additional studies are needed before it can be used routinely in patient care." — verbatim from source

  Source
• 

  Nirmish Singla, M.D., M.Sc.

  Urology

  •

  Johns Hopkins Medicine (Brady Urological Institute)

  "These exciting findings deepen our understanding of the mechanisms of testicular cancer formation." "We not only have uncovered novel candidate biomarkers, but potentially actionable targets to treat this disease." — verbatim from source

  Source